Shang, Ya-xi
Wei, Shu-feng
Yang, Ke-peng
Liu, Yuan
Wei, Su
Dong, Xia
Wang, Xin-chang
Xie, Zhi-min
Fang, Ru-lu
Liang, Li-na
Li, Xiu-feng
Xu, Lei
Chen, Mu-zhi
Zhang, Kai-xian
Huang, Ji-yong
Wang, Le
Yang, You-guo
Liao, Hong-li
Xing, Gui-e
Zheng, Yu-ping
Li, Xiao-fen
Lin, Jing-lian
Shi, Cheng-qian
Zeng, Yong-ping
Mo, Li-dan
Sun, Fan
Li, Xiao-peng
Zhang, Zhuo
Chen, Kai
He, Zhao-chun
Liu, Jian-ping
Article History
Received: 26 August 2023
Accepted: 24 December 2023
First Online: 4 January 2024
Declarations
:
: This study was approved by the ethics committee of Fangshan Hospital, Beijing University of Chinese Medicine (FZY LK-2020–015), the ethics committee of the Second Affiliated Hospital of Zhejiang Chinese Medical University (2020-Y-003-IH01), and the ethics committee of Liuzhou People’s Hospital (GCP2021–015–01). The purpose and potential risks of the trial were fully explained to all participants and their families. Every participant was asked to provide written informed consent before participation.
: Not applicable.
: The authors declare no competing interests.